Ping Lin Yeap

Ping Lin Yeap

DIMPCB

PhD researcher & Gates Cambridge Scholar

Posts by Tags

accelerator

Six project teams accepted onto Phase II of the Cancer Tech Accelerator

less than 1 minute read

Published:

“Cancer Tech Accelerator, the entrepreneur training programme from Capital Enterprise dedicated to supporting cutting-edge oncology technology commercialisation, has announced that six teams from its 2024 cohort have been accepted onto Phase II of the accelerator. Selected from the 25 teams that took part in Phase I, three of the Phase II project teams will receive a £70,000 grant to continue development of their technology.” Read more on Cancer Tech Accelerator.

blog posts

Six project teams accepted onto Phase II of the Cancer Tech Accelerator

less than 1 minute read

Published:

“Cancer Tech Accelerator, the entrepreneur training programme from Capital Enterprise dedicated to supporting cutting-edge oncology technology commercialisation, has announced that six teams from its 2024 cohort have been accepted onto Phase II of the accelerator. Selected from the 25 teams that took part in Phase I, three of the Phase II project teams will receive a £70,000 grant to continue development of their technology.” Read more on Cancer Tech Accelerator.

cambridge

Cambridge Independent: #21toWatch 2025 winners revealed, showcasing emerging innovations and entrepreneurs across Cambridge and East of England

less than 1 minute read

Published:

“The 7th annual Awards – which spotlight the Top21 standout individuals, game-changing companies, and world-leading innovations from across Cambridge and the East of England – are regarded as a reliable, early indicator of the NextGen innovators set to impact and improve our world and future.” Read more on Cambridge Independent, Cofinitive, and Cambridge Network.

Six project teams accepted onto Phase II of the Cancer Tech Accelerator

less than 1 minute read

Published:

“Cancer Tech Accelerator, the entrepreneur training programme from Capital Enterprise dedicated to supporting cutting-edge oncology technology commercialisation, has announced that six teams from its 2024 cohort have been accepted onto Phase II of the accelerator. Selected from the 25 teams that took part in Phase I, three of the Phase II project teams will receive a £70,000 grant to continue development of their technology.” Read more on Cancer Tech Accelerator.

gates

homerton college

news

Cambridge Independent: #21toWatch 2025 winners revealed, showcasing emerging innovations and entrepreneurs across Cambridge and East of England

less than 1 minute read

Published:

“The 7th annual Awards – which spotlight the Top21 standout individuals, game-changing companies, and world-leading innovations from across Cambridge and the East of England – are regarded as a reliable, early indicator of the NextGen innovators set to impact and improve our world and future.” Read more on Cambridge Independent, Cofinitive, and Cambridge Network.